Tag: Vanda Pharmaceuticals Inc.

Finance

NASDAQ Gainers: Rediff.com India Limited (ADR) (NASDAQ:REDF), Keurig Green Mountain Inc (NASDAQ:GMCR), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Rediff.com India Limited (ADR) (NASDAQ:REDF) released its 4Q and full-year financial performance that showed somehow wanting results especially in the U.S. However, investors appeared to pay little attention to the U.S. business problems but instead looked forward to better results in the near future, just as the management promised. Rediff.com India Limited (ADR) (NASDAQ:REDF) stock performance was 23.01% in last session and finished the day … Continue reading NASDAQ Gainers: Rediff.com India Limited (ADR) (NASDAQ:REDF), Keurig Green Mountain Inc (NASDAQ:GMCR), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Jason Knox
Gilead Sciences GILD NASDAQ:GILD
Finance

Healthcare Losers: Bristol-Myers Squibb (NYSE:BMY), LDR Holding Corp (NASDAQ:LDRH), Vanda Pharmaceuticals (NASDAQ:VNDA), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Bristol-Myers Squibb Co (NYSE:BMY) and Urban Outfitters (URBN) retreated 6.1 percent and 3.6 percent respectively, after brokers lowered their ratings on these stocks. Weaker-than-expected first-quarter results and dismal second-quarter earnings guidance led Wal-Mart Stores (WMT) to drop 2.4 per cent. Bristol-Myers Squibb Co (NYSE:BMY) stock performance was -6.12% in last session and finished the day at $48.93. Traded volume was 28.56million shares in the last … Continue reading Healthcare Losers: Bristol-Myers Squibb (NYSE:BMY), LDR Holding Corp (NASDAQ:LDRH), Vanda Pharmaceuticals (NASDAQ:VNDA), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark DeFrance
FB Nasdaq FB Facebook
BioTech

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox
Finance

Why Need to Watch – Joe’s Jeans Inc (NASDAQ:JOEZ) , Deckers Outdoor Corp (NYSE:DECK) , Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) , MeadWestvaco Corp. (NYSE:MWV)

Joe’s Jeans, Inc. (NASDAQ:JOEZ) reported Q2 EPS of $0.01, $0.04 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.96 million. Joe’s Jeans Inc (NASDAQ:JOEZ) stock performance was 20.39% in last session and finished the day at $1.24. Traded volume was 4.28million shares in the last session and the average volume of the … Continue reading Why Need to Watch – Joe’s Jeans Inc (NASDAQ:JOEZ) , Deckers Outdoor Corp (NYSE:DECK) , Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) , MeadWestvaco Corp. (NYSE:MWV)

Colin Pettis